• Centers and Programs
  • Alzheimer's Disease Center
  • Center for Brain Injury and Repair
  • Center for Cognitive Neuroscience
  • Center for Functional Neuroimaging
  • Center for Sleep and Respiratory Biology
  • Center for Spirituality and the Mind
  • Mahoney Institute of Neurological Sciences
  • Multiple Sclerosis Program
  • Neuro-Ophthalmology Program
  • Smell and Taste Center
  • Vision Research Center
• Clinical Trials
  • Cognitive Neurology (Memory Disorders)
  • Epilepsy
  • Herpes Simplex Encephalitis
  • Multiple Sclerosis
  • Neuromuscular
  • Neuro-Oncology
  • Parkinson's Disease / Movement Disorders
  • Acute Stroke
  • Stroke Prevention

   

A multi-center, Phase 1-2a, open-label, Dosage-Escalation and randomized, double-blinded, placebo-controlled study of dimebon in Subjects with Huntington’s Disease

Primary Study Objective
To determine the safety and efficacy of Dimebon in patients with Huntington's disease

Study Population
Patients with Huntington's disease

Principal Investigators
Amy Colcher, MD

Contact Person
Mary Matthews RN, MS
Phone (215) 829-8560